IP Verse

Abbvie, Inc. V. Teva Pharmaceuticals, Inc. - 1:23-cv-00362

Explore the details of the Abbvie, Inc. V. Teva Pharmaceuticals, Inc. case under case number 1:23-cv-00362 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:23-cv-00362
Filing Date
Mar 30, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Teva Pharmaceutical Industries Ltd. -
AbbVie Inc. -

Patents Involved in the Case

There is a single patent involved in this case.

Application NumberPatent Number
-US11542239B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Mar 30, 2023Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc. (jdb) (Entered: 03/30/2023)PACER Document
Mar 30, 2023Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,542,239 B2. (jdb) (Entered: 03/30/2023)PACER Document
Mar 30, 2023Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/14/2023. Date of Expiration of Patent: 07/23/2039.Thirty Month Stay Deadline: 1/23/2026. (jdb) (Entered: 03/30/2023)PACER Document
Mar 30, 2023Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jdb) (Entered: 03/30/2023)PACER Document
Mar 30, 2023COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4101417.) - filed by AbbVie Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jdb) (Entered: 03/30/2023)PACER Document
May 4, 2023MOTION for Pro Hac Vice Appearance of Attorney Jennifer H. Roscetti, Danielle A. Duszczyszyn, William B. Raich, Constance P. Lee, Ryan V. McDonnell and Reinaldo Franqui Machin - filed by AbbVie Inc.. (Tigan, Jeremy) (Entered: 05/04/2023)PACER Document
May 18, 2023STIPULATION and [Proposed] Order Regarding Teva Defendants by AbbVie Inc.. (Tigan, Jeremy) (Entered: 05/18/2023)PACER Document
May 19, 2023SO ORDERED Granting 7 Stipulation and Proposed Order (*Reset Answer Deadlines: Teva Pharmaceuticals, Inc. answer due 7/3/2023). Signed by Judge Richard G. Andrews on 5/19/2023. (nms) (Entered: 05/19/2023)PACER Document
Jul 3, 2023Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals, Inc. filed by Teva Pharmaceuticals, Inc.. (Hoeschen, Nathan) (Entered: 07/03/2023)PACER Document
Jul 3, 2023ANSWER to 1 Complaint, Affirmative Defenses, COUNTERCLAIM against AbbVie Inc. by Teva Pharmaceuticals, Inc..(Hoeschen, Nathan) (Entered: 07/03/2023)PACER Document
Mar 30, 2023No Summons Issued. (jdb)PACER Document
Apr 5, 2023Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:23-cv-00362-RGA, 1:23-cv-00374-RGA (rjb)PACER Document
May 4, 2023SO ORDERED, re (D.I. 6 in 23-cv-362-RGA; D.I. 8 in 23-cv-133-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jennifer H. Roscetti, Danielle A. Duszczyszyn, William B. Raich, Constance P. Lee, Ryan V. McDonnell and Reinaldo Franqui Machin, filed by AbbVie Inc.. Signed by Judge Richard G. Andrews on 5/4/2023. Associated Cases: 1:23-cv-00133-RGA, 1:23-cv-00362-RGA(nms)PACER Document